Bruker Announces Advancement to Phase IIIb of the DHS Autonomous Rapid Facility Chemical Agent Monitor Program
January 11 2010 - 7:00AM
Business Wire
Bruker Detection Corporation today announced that it has
advanced to the last phase of the Department of Homeland Security
(DHS) Autonomous Rapid Facility Chemical Agent Monitor (ARFCAM)
Research & Development Program which is intended to develop the
3rd generation chemical detection capability for critical
infrastructure.
Bruker’s ARFCAM is a gas trace detector for the detection
of chemical warfare agents (CWAs) and toxic industrial chemicals
(TICs) based on Bruker’s proprietary RAID™ Ion Mobility
Spectrometry (IMS) technology. The ARFCAM is specifically
designed for long-term monitoring of ambient air for the presence
of hazardous chemical vapors in the interior or exterior of
critical government buildings, subways, airports and other
facilities.
With its own R&D investment, Bruker has also developed a
novel, combined Drugs and
Explosives trace detector,
called the DE-tector™, for airport and other check-point
applications. The DE-tector uses Bruker’s next-generation
RAID™ IMS technology with breakthrough improvements in
technology and detection algorithms for even further improved
detection capabilities, specificity and analytical robustness. The
DE-tector, which is being launched in 2010, is expected to
represent a major leap forward in explosives trace detection using
next-generation IMS technology with selectivity and specificity
that approaches that of mass spectrometry. The DE-tector
continues to benefit from the high sensitivity, robust and easy
operation, small size and relatively low cost of previous Bruker
high-performance IMS systems.
Mr. Frank Thibodeau, Vice President of Bruker Detection
Corporation, commented: “The ARFCAM R&D program consisted of a
challenging competitive and incremental development of chemical
detection technology under demanding environments which pushed the
limits of chemical point detection systems. The Bruker
ARFCAM prototype has performed very well in this development
program and has been selected by the U.S. Department of Homeland
Security for final development and field testing in Phase IIIb. We
are delighted to have been selected for the final phase of
ARFCAM, and believe that Bruker’s robust and proven
RAID™ IMS technology, unsurpassed detection capability, and
proprietary industry-leading false-alarm suppression have led to
this award. These technological features are also built into our
industry-leading RAID™-M handheld detector, RAID™-XP
portable combined chemical and gamma radiation detector,
RAID™-S2 shipboard detector, as well as our RAID™-AFM
Autonomous Facility Monitor for critical
building and infrastructure protection.”
ABOUT BRUKER DETECTION
Bruker Detection is a leading, global manufacturer and provider
of Chemical, Biological, Radiological, Nuclear and Explosives
(CBRNE) detection solutions for homeland and airport security
markets. For more information about Bruker’s CBRNE Detection
Business and Bruker Corporation (NASDAQ: BRKR), visit
www.bruker.com/detection
CAUTIONARY STATEMENT
Any statements contained in this presentation that do not
describe historical facts may constitute forward-looking statements
as that term is defined in the Private Securities Litigation Reform
Act of 1995. Any forward-looking statements contained herein are
based on current expectations, but are subject to risks and
uncertainties that could cause actual results to differ materially
from those projected, including, but not limited to, risks and
uncertainties relating to adverse changes in conditions in the
global economy and volatility in the capital markets, the
integration of businesses we have acquired or may acquire in the
future, changing technologies, product development and market
acceptance of our products, the cost and pricing of our products,
manufacturing, competition, dependence on collaborative partners
and key suppliers, capital spending and government funding
policies, changes in governmental regulations, realization of
anticipated benefits from economic stimulus programs, intellectual
property rights, litigation, and exposure to foreign currency
fluctuations and other risk factors discussed from time to time in
our filings with the Securities and Exchange Commission. These and
other factors are identified and described in more detail in our
filings with the SEC, including, without limitation, our recent
Proxy Statements on Schedule 14A, our annual report on Form 10-K
for the year ended December 31, 2008, our most recent quarterly
reports on Form 10-Q and our current reports on Form 8-K. We
expressly disclaim any intent or obligation to update these
forward-looking statements other than as required by law.
Photos/Multimedia Gallery Available:
http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6137223&lang=en
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jul 2023 to Jul 2024